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1. Introduction
In addition to original articles, the Journal of Oral Biosciences
also publishes review articles by prize-winners of the “Lion Dental
Research Award” and “Rising Members Award,” presented by the
Japanese Association for Oral Biology. The Journal also publishes
review articles featuring recent information presented in symposia
held during the annual meeting of the Association. In 2014, we
published special issues featuring the following reviews: “A new
concept of bioﬁlm-mediated oral diseases—symbiosis and dysbio-
sis—,” “Morphological and functional dynamics of salivary gland,”
“Mouse genetics approaches decipher molecular mechanisms
of craniofacial development,” “Oral microbiome and bioﬁlm
research: new concepts and new approaches,” “Mechanisms of
tissue destruction by periodontal pathogens: current status and
future view,” “Salivary glands,” “Osteocyte biology,” “Involvement
of epigenetics in development of diseases—involvement of epige-
netics in inﬂammatory oral diseases,” “The front line of research
on oral microbiota,” and “Novel challenge for bone formation and
bone resorption,” in addition to review articles by invited authors
in the ﬁelds of “Geriatric oral biology,” “Regenerative medicine,”
and “Microbiology.” These reviews in the Journal of Oral Biosciences
have inspired the readers of the Journal to broaden their knowl-
edge regarding various aspects of the oral biosciences. The current
editorial review introduces these exciting review articles.
2. A new concept of bioﬁlm-mediated oral diseases—symbiosis
and dysbiosis
Healthy periodontal tissue is maintained through symbiosis
between the host immune system and bacterial plaques composed
of more than 800 bacterial species. This symbiosis is dependent on
the competence of the host immune system and the quantity of
bacterial plaques [1]. If the host immune system is unable to cope
with the pathogenic bacteria, gingivitis may occur and eventually
result in irreversible periodontitis. Not all bacteria in the bioﬁlm
are equally pathogenic, and Aggregatibacter actinomycetemcomi-
tans and Porphyromonas gingivalis show particularly strong asso-
ciations with periodontitis [2]. On the basis of current research on
the interaction of A. actinomycetemcomitans with the host immune
system, Nagasawa and colleagues in their review article summar-
ized A. actinomycetemcomitans-associated periodontitis as a model
for symbiosis and dysbiosis in periodontal disease [3].
They proposed that elucidation of host-microbial coevolution
may enable increased understanding of the dysbiosis that
is caused by A. actinomycetemcomitans, and discussed strategies
for developing diagnostic and treatment methods for A.
actinomycetemcomitans-associated periodontitis. Molecular mimi-
cry of human β2-glycoprotein I by A. actinomycetemcomitans is
associated with certain systemic diseases or conditions, including
threatened preterm labor, preterm birth, and Buerger's disease,
suggesting that molecular mimicry between the host and period-
ontopathic bacteria could be a strategy by which bacteria evade
the hosts' immune system. A particular clone (JP2) of A. actinomy-
cetemcomitans is considered to be a possible etiological agent of
the aggressive periodontitis in adolescents living in, or originating
from, North and West Africa [4]. The evidence suggests that
periodontopathic bacteria coevolved with their hosts, and that
their strategy for survival includes inducing dysbiosis in suscep-
tible hosts. Extensive research on host-microbial coevolution may
enable development of de novo molecular diagnostic methods and
efﬁcient treatment of periodontitis.
3. Morphological and functional dynamics of salivary gland
Hyposecretion of saliva and consequent dry mouth can lead to
severe dental caries, periodontal disease, and mucosal infections.
In order to investigate the causal mechanisms of hyposalivation, a
dry mouth animal model is required. Also of relevance are
aquaporins (AQPs), a family of small, integral plasma membrane
proteins that primarily transport water across the membrane. To
date, 13 mammalian AQP isoforms (AQP0–12) have been identi-
ﬁed, and each exhibits a unique pattern of expression in epithelial
tissue [5]. Of the 13 isoforms, AQP5 is highly expressed in salivary
and lacrimal glands, and plays an important role in the exocrine
function of these glands [5]. Recently, Senpuku and colleagues
established E2f1-deﬁcient non-obese diabetic/severe combined
immunodeﬁciency disease (NOD/SCID.E2f1/) in mice [6]. Satoh
and colleagues reviewed these NOD/SCID.E2f1/ mice, which
constitute a convenient in vivo model of dry mouth [7]. Investiga-
tions have revealed the following: (1) NOD/SCID.E2f1 / mice
demonstrate dry mouth characteristics, (2) NOD/SCID.E2f1 /
mice have more ducts in the salivary glands than NOD/SCID mice,
and (3) diffuse localization, ubiquitination, and reduction of
expression of AQP5 are observed in the salivary gland cells of
NOD/SCID.E2f1/ mice. Recent papers have reported how NOD/
SCID.E2f1/ mice can be employed for the study of the initial
colonization by streptococci, Actinomyces naeslundii and Candida
albicans, that occurs as a result of the dry mouth trait [8–10]. The
NOD/SCID.E2f1/ mice have wide potential application to studies
on not only dry mouth, but also oral diseases related to
hyposalivation.
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4. Mouse genetics approaches decipher molecular
mechanisms of craniofacial development
The actin cytoskeleton mediates a variety of essential biological
functions in eukaryotic cells [11] and shows global structural
rearrangement in response to extracellular signals that are trans-
duced via diverse cell surface receptors [12]. These extracellular
signals are converted into intracellular signals via Rho GTPase
protein family members, such as Rac1 and Cdc42, that are
intracellularly expressed [13]. Early studies demonstrated the
important role of Rac1 and Cdc42 in a number of essential
biological functions in various mammalian cell lines. However,
their functions in vivo, especially in mammalian limb develop-
ment, are not fully understood [14,15]. Yamada and colleagues
summarized the functions of Rac1 and Cdc42 in interdigital
programmed cell death, and condensation of mesenchymal cells
during limb-bud development was identiﬁed using limb-bud
mesenchyme-speciﬁc deletion of the Rac1 and Cdc42 genes in
mice [16]. Adams-Oliver syndrome (AOS) is a multiple congenital
anomaly syndrome that is characterized by aplasia cutis congenita
and transverse limb defects [17,18]. The Rho GTPase-activating
protein (GAP) 31 (encoded by the ARHGAP31 gene in humans) is a
member of the RhoGAP family of proteins that are known to
inactivate the Rac1 and Cdc42 regulatory proteins [19], and it was
recently proposed as a candidate gene for AOS [20]. Gain-of-
function mutations of ARHGAP31 in patients who have limb-
abnormality phenotypes typically affect the distal phalanges or
entire digits, and even, in rare cases, the more proximal limb
structures [20]. In addition, another AOS candidate gene, DOCK6, a
member of the Rho guanine nucleotide exchange factor family of
proteins that are also known to activate Rac1 and Cdc42 [21], was
identiﬁed in an investigation of AOS families [22]. Further studies
of limb development regulated by Rac1 and Cdc42 are required, in
order to clarify these mechanistic insights and conﬁrm the
molecular processes identiﬁed using tissue-speciﬁc gene knockout
mouse models.
5. Oral microbiome and bioﬁlm research: new concepts and
new approaches
Oral bioﬁlms are complex, multi-species, structured bacterial
communities that are found in the oral cavities and on the gingival
tissue surfaces. Over 500 species of bacteria have been identiﬁed
within the human oral cavity, and these have been shown to
trigger periodontal diseases [23–27]. Species of the Streptococcus
and Actinomyces genera are the predominant species, and they
primarily colonize the pellicle on the tooth surface and the
gingival epithelial cells [25–31]. A. naeslundii (formerly Actino-
myces viscosus), a Gram-positive facultative rod species, which is
known to frequently colonize tooth surfaces, has been isolated
from oral cavities and gingival pockets [32]. Among the Gram-
positive oral bacteria that have been studied to date, ﬁmbriae have
been particularly well characterized in A. naeslundii [33]. It is
evident that A. naeslundii induces inﬂammation in periodontal
tissues and causes destruction of the soft and hard tissues within
the root canal and gingival crevice. Hamada and colleagues
primarily focused on the properties of A. naeslundii peptidoglycan
(PGN), and described its structure and function in osteoclastogen-
esis, and its effect on inﬂammatory cytokine expression in the
immune system [34]. Their review indicated that A. naeslundii PGN
induces the production of inﬂammatory cytokines and activates
osteoclasts in alveolar bone resorption. Therefore, they suggested
that A. naeslundii PGN may be involved in the inﬂammatory
reactions associated with gingivitis and periodontitis, and an
important periodontal pathogenic factor in the development of
alveolar bone resorption. Analysis of the PGN signaling pathway
could contribute to the prevention of periodontal diseases in the
future.
6. Mechanisms of tissue destruction by periodontal
pathogens: current status and future view
P. gingivalis, a primary etiological agent of several forms of
severe periodontal disease, is most virulent under ecologically
imbalanced conditions [35]. The pathogen possesses numerous
potent virulence factors, including ﬁmbriae, lipopolysaccharide,
and proteases termed gingipains, which are aimed at neutralizing
local host defenses and destroying periodontal tissues. In addition
to these virulence factors, P. gingivalis, in common with most
Gram-negative bacteria, produces outer membrane vesicles
(OMVs), which serve as bacterial “bullets” for directed intercellular
transport of bacterial virulence factors into host cells and tissues.
The pathogen can utilize two unique transcellular invasive
mechanisms that result in cellular impairment and, thus, lead to
periodontal destruction; one is direct bacterial entry into period-
ontal cells [36] and the other is bacterial “shooting” of OMVs into
other periodontal cells [37]. Amano and colleagues addressed the
remarkable strategies used by intracellular P. gingivalis and OMVs.
P. gingivalis can both enter and exit periodontal cells via a
sophisticated strategy, which promotes the spread of periodontal
infection. Such efﬁcient bacterial entry likely contributes to peri-
odontal destruction, which may be further enhanced by mutual
communication within a complex polymicrobial etiology [35].
However, OMVs cannot escape from endocytic compartments,
wherein the endosome-incorporated materials are thought to
reside [37,38]. Thus, it is unclear how viable P. gingivalis promotes
its own escape from host cells. Furthermore, intracellular
dynamics are likely dependent on bacterial virulence factors, such
as ﬁmbriae and gingipains [36]. The protein expression proﬁles of
viable bacteria can vary, and this may regulate bacterial fate
according to intracellular circumstances; further studies are neces-
sary to understand the underlying mechanism of action. Although
analyses of the bacterial strategies used by P. gingivalis in order to
determine intercellular persistence, dissemination, and fate have
provided important information, they have unveiled only part of
the picture. Nevertheless, recent studies have shown that human
oral epithelial cells harbor a large intracellular bacterial load that
resembles the polymicrobial nature of tooth-surface bioﬁlm [39].
In addition, no signiﬁcant induction of apoptosis or necrosis has
been observed in epithelial cells persistently infected by bacteria
[40]. These new ﬁndings suggest that intracellular periodontal
bacteria reside in a largely dormant state that allows them to
persist within, but not destroy, the host cell.
Staphylococcus aureus is an important oral bacterium [41] that
is isolated in approximately 20% of specimens obtained from the
oral cavity and facial area [42]. S. aureus was isolated from 12% of
supragingival plaque samples of healthy dentate adults [43].
Approximately 28% of tongue swabs obtained from children,
who had no diseases other than dental disease, were S. aureus-
positive [44]. The isolation of S. aureus from the oral cavity
increases to more than 30% of samples in periodontal disease
patients [45]. Some oral diseases are caused, at least in part, by S.
aureus, such as angular cheilitis [46], parotitis [47], and staphylo-
coccal mucositis [48]. S. aureus infection-mediated diseases are
caused by the virulence factors produced by this pathogen. In
addition to enterotoxins and hemolysins, S. aureus secretes several
extracellular proteases, including the V8 serine protease, the
aureolysin metalloprotease, and the staphopain cysteine proteases,
ScpA and SspB; these enzymes are considered to be putative
virulence factors [49,50]. Staphopains are the most abundant
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proteases among extracellular proteolytic enzymes of staphylococci
[49]. In his review, Imamura focused on the pathophysiology of S.
aureus bacteremia and staphopain virulence activities associated
with septic shock, coagulation disorders, and infectious endocarditis
[51]. S. aureus in the oral cavity invades the bloodstream in high
numbers following dental procedures, and releases staphopains
into the plasma. By cleaving kininogens and ﬁbrinogen in plasma,
staphopains lower blood pressure through kinin release, and impair
plasma clottability. Staphopains degrade type I collagen, which
possibly contributes to endocardium destruction by S. aureus. These
pathogenic activities of staphopains suggest that the S. aureus-
produced proteases are potent virulence factors, which are poten-
tially involved in the induction of septic shock and coagulation
disorders, and in the onset of infectious endocarditis in S. aureus
bacteremia. In addition, staphopain activities are associated with
local S. aureus infections. Edema occurs through kinin release,
unclottable ﬁbrinogen generation impedes the induction of coagu-
lation in the host defense against pathogens, and collagen degrada-
tion destroys tissues, thereby facilitating S. aureus invasion into the
circulation and its dissemination. Therefore, staphopains may be
novel targets for drug development in the therapy of infectious
diseases caused by S. aureus.
P. gingivalis is a Gram-negative anaerobic bacterium that
colonizes dental plaque bioﬁlms in the human oral cavity and
plays a key role in the initiation and progression of chronic
periodontitis [35]. Previously, Hasegawa and colleagues found that
Mfa1-type ﬁmbriae are elongated in P. gingivalis strain 33277,
which is deﬁcient in the mfa2 gene [52]. They identiﬁed the gene
products, PGN0289 (Mfa3), PGN0290 (Mfa4), and PGN0291
(Mfa5), as accessory proteins, and observed that they copuriﬁed
with Mfa1 ﬁmbriae. Furthermore, they discovered that Mfa3 is
located at the ﬁmbrial tip, and is necessary for Mfa4 and Mfa5
assembly [53]. Hasegawa and Murakami reviewed their most
recent discoveries regarding the proteins produced by the mfa1
downstream gene cluster, and discussed similarities in both
localization and function between the products of the mfa1 and
ﬁmA gene clusters [54]. The precursors of both FimA and Mfa1 are
processed by the arginine gingipain, Rgp [55,56] and signal
peptidase II [57]; however, this processing is only poorly under-
stood. Furthermore, they discussed the putative processing of
ﬁmbrial components based on analysis of the amino acid sequence
of their N-terminal regions. The products of the mfa1 and ﬁmA
gene clusters are similar in both function and localization. Mfa2
and FimB, which localize to the outer membrane, appear to
regulate ﬁmbrial length and to play roles in anchoring ﬁmbriae
to the cell surface. Mfa3–5 and FimC–E are all accessory proteins
that are likely located at the ﬁmbrial tips and are involved in
ﬁmbrial function. Amino acid sequence analysis suggested that
Mfa1, Mfa3, and Mfa4 are processed by Rgp. In addition, with the
exception of Mfa5, the ﬁmbrial components of both Mfa1- and
FimA-type ﬁmbriae may be cleaved by signal peptidase II.
Commensal dental-plaque bacteria include numerous species
that are associated with periodontal health, and with diseases
such as periodontitis. Beneﬁcial protective oral bacteria are abun-
dant in healthy periodontal tissue but decrease in diseased tissue,
where several pathogenic oral bacteria proliferate instead. There-
fore, periodontitis has been known as dysbiosis of oral commensal
bacteria; however, the underlying mechanism of dysbiosis is not
known [58]. P. gingivalis secretes several proteases, which are
attached to the cell surface and/or extracellular vesicles in order to
function in extracellular digestion of proteins that are provided
from exogenous sources [59]. Saiki and Konishi reviewed the
assembly and function of three gene products involved in protein
secretion and modiﬁcation, PG27/LptO, PG0026, and HagA [60]. P.
gingivalis secretes C-terminal domain (CTD) proteins. CTD proteins
pass through the outer membrane via the Por secretion system,
undergo post-translational glycosylation by attaching deacylated
anionic-lipopolysaccharide (A-LPS), and anchor the outer cell
membrane and/or the extracellular vesicles. These secretion and
modiﬁcation steps vary depending on the particular CTD protein
but, in all cases, the CTDs of mature CTD proteins, except for the
CTD signal peptidase, are removed. Since CTD proteins such as
gingipains are known virulence factors of P. gingivalis, the mechan-
ism of secretion and modiﬁcation of CTD proteins needs to be
elucidated. Recent genetic studies have identiﬁed the genes
essential for the secretion and modiﬁcation of CTD proteins. Of
particular interest is the functional role of each component;
however, this issue is not easy to address. Recently, reports on
the roles of PG0026 and PG27/LptO in the modiﬁcation system
have been published [61,62]. PG0026 has been proposed as the
CTD signal peptidase, while PG27/LptO is bifunctional, as an outer
membrane protein consisting of a beta-barrel structure that
anchors PG0026 and HagA to the cell surface, and in the deacyla-
tion of A-LPS. The accumulation of data on the determination and
puriﬁcation of functional units in the secretion and modiﬁcation
system would help identify the overall structure of this system.
Periodontitis is an inﬂammatory disease accompanied by
alveolar bone resorption that is induced by chronic infection with
various bacteria, including P. gingivalis. P. gingivalis produces
gingipains, which function as cysteine proteases. Gingipains are
reported to play an important role in the establishment of chronic
P. gingivalis infection, as well as in the induction of inﬂammation
and the degradation of soft tissues [63]. In addition, several reports
have indicated that gingipains are involved in alveolar bone loss
[64–67]. Although the mechanisms by which gingipains cause
bone resorption have not been elucidated in detail, it has been
reported that a secreted form of the lysine-speciﬁc gingipain (Kgp)
promotes differentiation of osteoclasts, which in turn facilitates
bone resorption [68–70]. Miyamoto discussed the role of gingi-
pains in alveolar bone loss during periodontitis in his review
article, including his laboratory's recent ﬁndings that Kgp med-
iates proteolytic degradation of osteoprotegerin (OPG), a protein
that inhibits osteoclastogenesis [71]. They found that osteoclast
differentiation induced by active vitamin D3, Toll-like receptor
(TLR) ligands such as lipopolysaccharide, and inﬂammatory cyto-
kines such as tumor necrosis factor-α and interleukin-1β was
enhanced by secreted Kgp in cocultures of mouse osteoblasts and
bone marrow cells, whereas RgpB had no effect on osteoclast
differentiation under the same experimental conditions. The effect
of Kgp on osteoclast differentiation was completely blocked by an
inhibitor of Kgp. Furthermore, OPG was degraded by Kgp. Kgp-
mediated osteoclast differentiation was not observed in cocultures
of OPG-deﬁcient osteoblasts and bone marrow cells. Kgp degraded
OPG and enhanced osteoclastogenesis that was induced by TLR
ligands and inﬂammatory cytokines in vitro. Degradation of OPG
by Kgp may be a causal factor of bone loss in periodontitis.
7. Salivary glands
Multiple studies have been devoted to the identiﬁcation of
novel biomarkers of disease. An ideal biomarker should be able to
identify a disease in a precise manner, such as cancer, before the
clinical diagnosis is performed. To this end, easily accessible and
noninvasively obtained body ﬂuids containing biomarkers that
reﬂect a disease condition are particularly useful [72]. Many
biological components in the blood, such as enzymes, enter the
saliva by ultraﬁltration through the salivary glands. Saliva can thus
be useful for monitoring the physiological conditions of the human
body [73]. Since human saliva can be easily, noninvasively, and
inexpensively obtained, various salivary biomarkers have been
identiﬁed for both systemic and nonsystematic types of
Editorial / Journal of Oral Biosciences 57 (2015) 1–8 3
dysfunction [73–76]. Kashimata and colleagues summarized the
ﬁndings of recent studies on salivary microRNAs (miRNAs). Gene
therapy using artiﬁcial miRNAs delivered in exosomes is thought
to be beneﬁcial because of the characteristics of exosomes in the
saliva. Interestingly, a recent report described a mechanism by
which miRNAs are selected for packaging into exosomes in
primary T lymphoblasts [77]. Furthermore, small ubiquitin-
related modiﬁer (SUMO) proteins are attached to heterogeneous
nuclear ribonucleoprotein A2/B1 (HNRNPA2B1) that is found in
exosomes. Modiﬁcation by SUMOs affects the functions of proteins
by changing their stability, localization, and ability to interact with
other proteins [78]. Therefore, it has been suggested that sumoyla-
tion controls the binding of HNRNPA2B1 to miRNAs and sorts
them into exosomes [77]. These ﬁndings may prove helpful for the
development of gene therapy using artiﬁcial miRNAs packaged
into exosomes in saliva. Isolation of salivary miRNAs may lead to
the discovery of novel biomarkers for the diagnosis of diseases
such as oral cancer. Similarly, proﬁles of salivary miRNAs may
provide information on the physical, physiological, and mental
condition of patients. The investigation of salivary miRNAs is still
in the preliminary stages. Additional studies are required to
conﬁrm the applicability and usefulness of extracellular salivary
miRNAs for the diagnosis of diseases and for gene therapy.
Gene transfer can be useful for the treatment of diseases caused
by the lack of an important protein, such as insulin or erythropoie-
tin. The target organs of gene therapy should have the ability to
synthesize and secrete large amounts of proteins. Salivary glands
can secrete considerable amounts of proteins, both apically in saliva
and basolaterally into the blood circulation [79,80]. Because the
glands can be retrogradely accessed from the oral cavity through
the main excretory ducts, the effect of gene transfer would be
limited to the salivary glands. Therefore, there are many advantages
to using salivary glands for gene therapy. To achieve the efﬁcient
supply of exogenous proteins as drugs, however, it is necessary to
deliver them to the appropriate target. In their review, Fujita-
Yoshigaki and colleagues summarized the characteristics of amy-
lase, and its signal peptide sequence (SS25H) and sorting mechan-
ism, using an expression system that incorporated a reporter
protein, HaloTags, in order to monitor secretory pathways in
salivary glands [81]. They found that the HaloTags–SS25H fusion
protein was transported to secretory granules (SGs) and SS25H
secreted upon β-adrenergic stimulation [82]. However, the basal
secretion without stimulation was slightly higher than that of
amylase, suggesting that SS25H was partially transported via a
constitutive secretory pathway. Because the signal peptide
sequence is deleted after translocation into the endoplasmic reti-
culum, SS25H is fused to only the HaloTags amino acid sequence,
and no speciﬁc sorting signal, when sorted in the trans-Golgi
network. In addition, SS25H did not form oligomers in SGs. These
results suggest that the sorting of SS25H is completely passive.
Thus, it can be used as a standard protein that is not subject to any
regulation for sorting. It will be useful to study the effect of its
fusion with other proteins on transport efﬁciency via regulated
secretory pathways. Using the HaloTags technology provides useful
information about granule biogenesis and sorting mechanisms.
Saliva is an important body ﬂuid that reﬂects systemic and oral
conditions. Because saliva sampling is non-invasive, painless, stress-
free, and relatively simple compared to blood collection, saliva is a
useful tool for assessing health or disease states; these signiﬁcant
advantages make the discovery of salivary biomarkers associated
with health and diseases desirable. Saliva is mainly (99%) made up of
water, and the other 1% is composed of electrolytes, proteins,
peptides, polynucleotides, hormones, enzymes, cytokines, antibodies,
and other substances [83]. In recent years, proteomic technologies
have rapidly advanced the analysis of saliva, conﬁrming that 20–30%
of the salivary proteome overlaps with the plasma proteome [84,85].
In body ﬂuids, such as saliva, there are three main classes of
extracellular vesicles, exosomes, microvesicles, and apoptotic bodies
[86–88]. In contrast to microvesicles, which are generated by shed-
ding from the plasma membrane, exosomes are derived from multi-
vesicular bodies that are components of the endocytic pathway [89].
Ishikawa and colleagues summarized studies of membrane transpor-
ters in salivary exosomes, and of microvesicles as biomarkers of
systemic or oral disease [90]. Biomarker discovery is now progressing
with regard to analysis of salivary exosomes and microvesicles.
Membrane transporters in whole saliva, as well as salivary exosomes
and/or microvesicles, may be useful biomarkers for disease diagnosis.
For example, xerostomia can be diagnosed based on salivary AQP5
levels. Salivary glands contain various ion channels, such as chloride
channels [91], which may also be useful as biomarkers for systemic
or oral disease diagnosis.
8. Osteocyte biology
Osteocytes form a network in bone that is composed of two
communication systems; one is an intracellular communication
system that functions via gap junction-coupled cellular processes,
and the other is an extracellular communication system that
functions through the canaliculi. The two communication systems
extend to osteoblasts on the bone surface [92]. Both are required
for the survival of osteocytes because osteocytes acquire nutrients,
oxygen, and survival signals through them [93]. Furthermore,
osteocytes release secreted factors through the extracellular com-
munication system to the bone surface and to vascular canals in
the bone. The osteocyte network is thought to be an ideal
mechanosensory system for mechanotransduction, by which
mechanical energy is converted into electrical and/or biochemical
signals [94–99]. However, the lack of suitable animal models
makes proving this difﬁcult. Komori's review focused on the
differing roles of dead and live osteocytes [100]. Because apoptotic
osteocytes are not eliminated by scavenger cells, they undergo
secondary necrosis, which in turn induces bone resorption at the
damaged area as a repair process; however, this is not due to loss
of live osteocyte function. Live osteocytes stimulate osteoclasto-
genesis and bone resorption, and their functions are augmented
under unloaded conditions. Thus, osteocytes stimulate bone
resorption when alive or dead.
9. Involvement of epigenetics in development of diseases—
involvement of epigenetics in inﬂammatory oral diseases
Epigenetic modiﬁcations are essential for stem cell regulation,
their subsequent differentiation during development, and in the
adult body. Aberrant epigenetic changes may induce malignancy
or other acquired diseases, and aberrant methylation is well
documented in malignant and premalignant lesions [101,102].
Epigenetic modiﬁcations may cause other common diseases, such
as diabetes, metabolic diseases, allergies, autoimmune diseases,
and neurodegenerative diseases [103–106]. Recently, epigenetic
alterations have been implicated in the development of period-
ontal disease [107–109]. These studies have concentrated on
alterations in the methylation proﬁle as the major epigenetic
change. Abiko and colleagues summarized recent publications on
methylation in oral inﬂammatory diseases, in order to discuss
methylation as a cause of disease and make recommendations
about therapeutic targets [110]. DNA methylation in oral cancer is
well documented. Evidence for a role of epigenetic modiﬁcation in
degenerative and inﬂammatory diseases, as well as in malignant
neoplasms, is growing. Oral tissues are exposed to numerous
environmental factors, including microbes, food, tobacco, and
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alcohol, but little is known about their impact on degenerative and
inﬂammatory diseases. Because epigenetic modiﬁcation is rever-
sible, it may be useful as a therapeutic target. Epigenetic therapy
may have applications in refractory oral inﬂammatory diseases,
such as lichen planus and recurrent aphthous stomatitis, although
little is known about epigenetic modiﬁcations in these diseases.
Further investigation is needed before progress can be made in the
ﬁeld of epigenetic therapy for oral diseases.
10. The front line of research on oral microbiota
Currently, over 700 bacterial species have been identiﬁed from the
human oral cavity. The bacteria generally colonize by forming micro-
bial bioﬁlms and overcome numerous challenges associated with
retention in the oral cavity, such as high salivary ﬂow and low nutrient
ﬂow. Genetically distinct cell types physically interact with the
hundreds of human oral bacterial strains that have been examined
[111]. Similarly, speciﬁc adhesion between different bacterial species
contributes to the development of oral bioﬁlms [112]. Many of the
speciﬁc adherence interactions in dental plaque appear to involve cell-
associated lectins of one organism that interact with carbohydrates on
another organism [113]. In their review, Yoshida and colleagues
focused on cell surface coaggregation of oral streptococci [114]. Insight
into the genetic basis of receptor polysaccharide (RPS) structure and
function was gained from comparative characterization of gene
clusters that are involved in RPS production; this occurs in different
streptococci by carbohydrate engineering, which involves gene swap-
ping between strains to obtain polysaccharides with altered structural
and biological properties. Production of genetically modiﬁed polysac-
charides on bacterial cell surfaces (e.g., by carbohydrate engineering)
has a wide range of potential applications in basic research on
polysaccharide structure and function, as well as in the possible
production of new or improved vaccines. In addition, comparison of
the structures of original and modiﬁed polysaccharides leads to
elucidation of the function of polysaccharide biosynthetic genes.
11. Novel challenge for bone formation and bone resorption
The importance of purine nucleotides and nucleosides in the
human body is widely known. Investigations into the role of ATP
started in the 1920s, when important articles detailing its dis-
covery were simultaneously published by independent groups.
The potent actions of numerous purine nucleotides and nucleo-
sides, including ATP and adenosine, on the heart, blood vessels,
and muscles were ﬁrst reported in 1929 [115–117]. Since these
early publications, the continuing study of ATP has provided
further insights into its structure and function, highlighting the
importance of this molecule in a multitude of processes and
tissues. Once ATP is released into the extracellular space, it is
rapidly degraded to ADP, AMP, and adenosine by ectonucleotidases
[118,119]; these adenine nucleotides and the nucleoside have
additional functions to those of ATP. The vast number of tissue-
speciﬁc functions of ATP-mediated purinergic signaling have been
widely investigated and reviewed. Iwamoto and colleagues sum-
marized the function of purinergic signaling in three speciﬁc
tissues, bone, cartilage, and teeth, in their review article [120].
Their data indicated that purinergic signaling is involved in
osteogenesis and chondrogenesis, as well as dental sensory
perception. The downstream effects of ATP-mediated signaling
appear to be largely determined by the receptors expressed in
each tissue, as well as the differentiation stage of the cells.
Although the function of each tissue type highlighted in this
review is different, ATP is an essential signaling molecule for
proper development and regulation of each tissue. This review
serves not only to show how much we have learned since the
initial connections between ATP, purinergic signaling, and tissue
development were made, but also to stress how much is still
unknown. Fully elucidating the role of the purinergic receptors
and their downstream signaling cascades in cells found in bone,
cartilage, and teeth will allow us to better understand the function
of signaling molecules such as ATP in normal tissue homeostasis,
as well as to identify potential targets for the development of
novel therapeutics in disease treatment.
12. Geriatric oral biology
The elderly exhibit increased susceptibility to a number of
autoimmune, inﬂammatory, or infectious diseases, and aging is
similarly thought to be associated with increased prevalence and
severity of periodontitis [121–127]. Aging is also associated with
increased severity of naturally occurring periodontitis in non-
human primates and rodents, which are thus useful models for
investigating relevant age-related alterations [128,129]. The
impact of aging on periodontitis is poorly understood at the
mechanistic level. It has been suggested that aging per se does
not necessarily cause periodontitis [130], which is consistent with
the notion that aging is not a disease [131]. Most of the studies on
aging have investigated in vitro functional differences between cell
types isolated from young or old subjects. Although ﬁndings from
such studies may not always be relevant to the in vivo setting, the
most important ﬁndings were discussed and summarized in the
review article by Hajishengallis and colleagues, and they provided
insights into how aging may potentially inﬂuence the immune
response [132]. Overall, the objective of this review was to
synthesize available literature into useful concepts for better
understanding the complex interplay between aging and inﬂam-
matory diseases, such as periodontitis, and to provide stimuli for
future research. A number of studies have shown that aging causes
functional alterations to innate immune cells. These ﬁndings offer
insights into how aging could potentially inﬂuence immune and
inﬂammatory responses; alterations in these responses could in
turn increase susceptibility to chronic diseases such as period-
ontitis. However, most of the work in this area of research involves
in vitro studies, in which cells are isolated from their native tissue
environment. Furthermore, tissues are not passive subjects of
immune surveillance, as they can regulate the recruitment and
activation of leukocytes via tissue-derived signals, and can thereby
provide homeostatic protection against inﬂammatory diseases. In
other words, age-related altered function of immune cells in vivo
may not necessarily reﬂect cell-intrinsic genetically-encoded
developmental programs, but may alternatively or additionally
involve age-dependent changes in the tissue environment where
the cells act. Novel integrative approaches are warranted for better
understanding of how aging can affect the immunoinﬂammatory
status in the elderly, and consequently their risk for periodontitis
and other age-related diseases. The elucidation of causal mechan-
isms of innate immune dysfunction in old age may answer current
puzzling questions as to the precise relationship between “inﬂam-
maging” and inﬂammatory/degenerative diseases, and the exact
role of aging in periodontitis. Most importantly, integrative
approaches have the potential to facilitate the development of
targeted molecular therapies that can beneﬁt the elderly.
13. Regenerative medicine
For many years, Baum has been interested in what he considers to
be the failure of dental education, to recognize the importance of
biology and medicine to dental practice, as well as to fully embrace
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both of these in planning for the future of the dental profession
[133,134]. Indeed, he has long believed that biology would provide
dentistry, and thus dental patients, with the profession's next “ﬂuor-
ide-like” advance [135]. The latter is yet to be achieved, and he has
found that dentistry and oral biology, in much of the world, is
separated from mainstream biomedical science. Baum hoped, through
the review article (narrative), that he could transmit some of the
lessons he learned, and applied to his work in gene therapy, to the
readership of the Journal of Oral Biosciences. He began his review
article by stating that he hoped his experiences in developing a clinical
gene therapy strategy would be helpful to a broad range of oral
biologists. Six lessons were discussed: (1) reading extensively outside
of oral biology in order to learn what is happening in the wider
biomedical research community that may potentially be applicable to
your work; (2) not being afraid to have a good imagination and “see”
possibilities that others may not recognize; (3) not being afraid to
change direction in your research, even in the middle of a reasonably
successful career; (4) not hesitating to seek expert help when trying
something new, as it is better to quickly and efﬁciently test ideas
rather than stumble along, trying to work things out on your own;
(5) trying to think long term, but having deﬁnite short term goals that
are achievable, and, thus, encouraging to you and your colleagues;
(6) following the wise advice of the French writer, Voltaire, “don’t let
the perfect be the enemy of the good” (originally, “le mieux est
l’ennemi du bien”). Early on in his endeavor to develop a clinical gene
therapy strategy, Baum recalled most people offering criticism of one
thing or another in his strategy, because it was imperfect, not “ideal”, e.
g., using an early adenoviral vector that was known to elicit a
signiﬁcant inﬂammatory response. In such situations, Voltaire's advice
was invaluable, since for patients who have no other options, it is
reasonable to try something that may be good and helpful, as long as it
is shown to be safe, rather thanwaiting until “perfection” comes along.
14. Microbiology
Periodontal diseases are polymicrobial inﬂammatory-associated
infectious diseases that can lead to the destruction of periodontal
ligaments and adjacent supportive alveolar bone. The oral cavity
harbors more than 680 bacterial species [136–138], and some of these
microorganisms have been shown to be responsible for the initiation
and progression of periodontal diseases [139,140]. In their review,
Fletcher and colleagues focused on the pattern of microbial synergy
exhibited by members of the expanded red complex, and by other
bacterial species, which enables them to survive cooperatively and
individually in the oxidatively stressed environment of the periodontal
pocket [141]. Proteomics studies have proven very insightful in the
revelation of biological events that are relevant to multispecies
bacterial interactions [142]. Systems approaches, which have been
successful in modeling and simulating gut microbiome–host intestinal
transcriptome interactions, are gainingmomentum in their application
to the further understanding of oral microbiome interactions [143].
Moreover, an understanding of the complex interactions between the
diverse oral microbial community and the host, as well as of the
potential mechanism(s) whereby the oral microbiome impact a
disease, is starting to emerge. Further application of systems
approaches to the study of periodontal disease could have a tremen-
dous impact on the development of novel therapeutics in the
near future
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